Search by Drug Name or NDC
NDC 61919-0865-30 PHENTERMINE HCL C-IV 30 mg/1 Details
PHENTERMINE HCL C-IV 30 mg/1
PHENTERMINE HCL C-IV is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is PHENTERMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
Related Packages: 61919-0865-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Phentermine
Product Information
NDC | 61919-0865 |
---|---|
Product ID | 61919-865_f9261f0d-fcef-339c-e053-6394a90a6f51 |
Associated GPIs | 61200070100115 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | PHENTERMINE HCL C-IV |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | PHENTERMINE HCL C-IV |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 30 |
Active Ingredient Units | mg/1 |
Substance Name | PHENTERMINE HYDROCHLORIDE |
Labeler Name | Direct_Rx |
Pharmaceutical Class | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
DEA Schedule | CIV |
Marketing Category | ANDA |
Application Number | ANDA091359 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0865-30 (61919086530)
NDC Package Code | 61919-865-30 |
---|---|
Billing NDC | 61919086530 |
Package | 30 CAPSULE in 1 BOTTLE (61919-865-30) |
Marketing Start Date | 2019-06-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |